Cannabinoids exert their physiological effects through interactions with cannabinoid receptors 1 (CB1) and 2 (CB2), which are GPCRs classified as Ga i/o-type and are thought to reduce cellular cAMP levels, ultimately leading to apoptosis and suppression of cancer development [41]. The gene discussed is CNR2; the disease is cancer.